State Street’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-75,913
| Closed | -$85K | – | 4329 |
|
|
2025
Q2 | $85K | Sell |
75,913
-417,785
| -85% | -$510K | ﹤0.01% | 4005 |
|
|
2025
Q1 | $568K | Buy |
493,698
+34,247
| +7% | +$63.7K | ﹤0.01% | 3567 |
|
|
2024
Q4 | $2.81M | Sell |
459,451
-10,339
| -2% | -$123K | ﹤0.01% | 3204 |
|
|
2024
Q3 | $7.77M | Buy |
469,790
+12,174
| +3% | +$133K | ﹤0.01% | 2751 |
|
|
2024
Q2 | $3.14M | Buy |
457,616
+138,347
| +43% | +$1.18M | ﹤0.01% | 3125 |
|
|
2024
Q1 | $3.08M | Buy |
319,269
+11,801
| +4% | +$137K | ﹤0.01% | 3121 |
|
|
2023
Q4 | $2.56M | Buy |
307,468
+18,371
| +6% | +$107K | ﹤0.01% | 3232 |
|
|
2023
Q3 | $2.41M | Buy |
289,097
+27,848
| +11% | +$236K | ﹤0.01% | 3249 |
|
|
2023
Q2 | $2.41M | Buy |
261,249
+31,443
| +14% | +$352K | ﹤0.01% | 3327 |
|
|
2023
Q1 | $3.16M | Buy |
229,806
+3,651
| +2% | +$75.5K | ﹤0.01% | 3161 |
|
|
2022
Q4 | $3.85M | Buy |
226,155
+4,205
| +2% | +$84.1K | ﹤0.01% | 3154 |
|
|
2022
Q3 | $5.05M | Buy |
221,950
+34,689
| +19% | +$700K | ﹤0.01% | 3055 |
|
|
2022
Q2 | $3.38M | Buy |
187,261
+15,679
| +9% | +$279K | ﹤0.01% | 3291 |
|
|
2022
Q1 | $4.59M | Sell |
171,582
-560,138
| -77% | -$10.4M | ﹤0.01% | 3225 |
|
|
2021
Q4 | $21.5M | Buy |
731,720
+75,697
| +12% | +$3.76M | ﹤0.01% | 2433 |
|
|
2021
Q3 | $43.1M | Buy |
656,023
+69,185
| +12% | +$5.29M | ﹤0.01% | 1912 |
|
|
2021
Q2 | $48.8M | Sell |
586,838
-100,377
| -15% | -$7.44M | ﹤0.01% | 1864 |
|
|
2021
Q1 | $52.7M | Buy |
687,215
+142,642
| +26% | +$13M | ﹤0.01% | 1713 |
|
|
2020
Q4 | $48.1M | Buy |
544,573
+215,407
| +65% | +$15.1M | ﹤0.01% | 1657 |
|
|
2020
Q3 | $24.3M | Buy |
329,166
+23,050
| +8% | +$1.36M | ﹤0.01% | 1913 |
|
|
2020
Q2 | $22.3M | Buy |
306,116
+219,303
| +253% | +$13.3M | ﹤0.01% | 1962 |
|
|
2020
Q1 | $4.88M | Buy |
86,813
+32,038
| +58% | +$1.4M | ﹤0.01% | 2641 |
|
|
2019
Q4 | $2.09M | Buy |
+54,775
| New | +$1.38M | ﹤0.01% | 3234 |
|
Other funds holding IGMS
State Street's IGMS Position: Q3 2025 in Review
State Street sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 75,913 shares — an estimated $85K sold.
State Street first reported a position in IGMS in Q4 2019 and held it in 23 quarters. The position peaked at $52.7M in Q1 2021. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- State Street reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- State Street sold 75,913 IGM Biosciences shares in Q3 2025, an estimated $85K.
- State Street first reported a position in IGM Biosciences in Q4 2019 and held it in 23 quarters.
- State Street's IGM Biosciences position peaked at $52.7M in Q1 2021.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on State Street's 13F filing for Q3 2025, filed 14 Nov 2025.